25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

IPCA LABORATORIES LTD.
Buy, Hold or Sell?

Let's analyze Ipca together

I guess you are interested in IPCA LABORATORIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of IPCA LABORATORIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about IPCA LABORATORIES LTD.

I send you an email if I find something interesting about IPCA LABORATORIES LTD..

1. Quick Overview

1.1. Quick analysis of Ipca (30 sec.)










1.2. What can you expect buying and holding a share of Ipca? (30 sec.)

How much money do you get?

How much money do you get?
INR0.10
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR304.57
Expected worth in 1 year
INR601.76
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR305.19
Return On Investment
19.2%

For what price can you sell your share?

Current Price per Share
INR1,587.80
Expected price per share
INR1,430 - INR1,709
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Ipca (5 min.)




Live pricePrice per Share (EOD)
INR1,587.80
Intrinsic Value Per Share
INR-4.20 - INR226.84
Total Value Per Share
INR300.36 - INR531.41

2.2. Growth of Ipca (5 min.)




Is Ipca growing?

Current yearPrevious yearGrowGrow %
How rich?$919.5m$695.2m$224.3m24.4%

How much money is Ipca making?

Current yearPrevious yearGrowGrow %
Making money$65.1m$56m$9m13.9%
Net Profit Margin7.2%7.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Ipca (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Ipca?

Welcome investor! Ipca's management wants to use your money to grow the business. In return you get a share of Ipca.

First you should know what it really means to hold a share of Ipca. And how you can make/lose money.

Speculation

The Price per Share of Ipca is INR1,588. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ipca.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ipca, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR304.57. Based on the TTM, the Book Value Change Per Share is INR74.30 per quarter. Based on the YOY, the Book Value Change Per Share is INR14.87 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR2.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ipca.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.260.0%0.260.0%0.220.0%0.340.0%0.230.0%
Usd Book Value Change Per Share0.880.1%0.880.1%0.180.0%0.430.0%0.270.0%
Usd Dividend Per Share0.020.0%0.020.0%0.050.0%0.040.0%0.030.0%
Usd Total Gains Per Share0.910.1%0.910.1%0.220.0%0.470.0%0.300.0%
Usd Price Per Share14.74-14.74-9.64-15.23-11.76-
Price to Earnings Ratio57.39-57.39-43.62-46.38-66.03-
Price-to-Total Gains Ratio16.23-16.23-42.95-37.90-67.26-
Price to Book Ratio4.07-4.07-3.52-6.50-6.69-
Price-to-Total Gains Ratio16.23-16.23-42.95-37.90-67.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share18.89482
Number of shares52
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.04
Usd Book Value Change Per Share0.880.43
Usd Total Gains Per Share0.910.47
Gains per Quarter (52 shares)47.2124.69
Gains per Year (52 shares)188.8598.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1518417999089
21036836818180188
31555255727270287
42073674636359386
52592093544449485
6301103112453539584
7351287131362629683
8401471150271719782
9451655169180809881
10501839188089898980

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of IPCA LABORATORIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--74.29874.2980%14.867+400%36.299+105%22.733+227%
Book Value Per Share--304.567304.5670%230.269+32%215.708+41%158.046+93%
Current Ratio--2.3512.3510%2.874-18%2.676-12%2.276+3%
Debt To Asset Ratio--0.3040.3040%0.323-6%0.289+5%0.333-9%
Debt To Equity Ratio--0.5330.5330%0.477+12%0.429+24%0.520+3%
Dividend Per Share--2.0002.0000%4.000-50%3.595-44%2.105-5%
Eps--21.57421.5740%18.578+16%28.766-25%19.216+12%
Free Cash Flow Per Share--21.02321.0230%12.272+71%17.409+21%12.310+71%
Free Cash Flow To Equity Per Share--21.02321.0230%32.265-35%21.285-1%11.553+82%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--226.839--------
Intrinsic Value_10Y_min---4.203--------
Intrinsic Value_1Y_max--18.598--------
Intrinsic Value_1Y_min--9.194--------
Intrinsic Value_3Y_max--59.029--------
Intrinsic Value_3Y_min--19.459--------
Intrinsic Value_5Y_max--103.258--------
Intrinsic Value_5Y_min--20.698--------
Market Cap402831211200.000+22%314149247938.500314149247938.5000%205576529466.000+53%324771784534.700-3%250653319427.350+25%
Net Profit Margin--0.0720.0720%0.075-5%0.128-44%0.100-28%
Operating Margin----0%0.127-100%0.142-100%0.119-100%
Operating Ratio--1.2351.2350%1.331-7%1.228+1%1.268-3%
Pb Ratio5.213+22%4.0664.0660%3.519+16%6.497-37%6.694-39%
Pe Ratio73.597+22%57.39557.3950%43.617+32%46.378+24%66.026-13%
Price Per Share1587.800+22%1238.2501238.2500%810.300+53%1280.120-3%987.975+25%
Price To Free Cash Flow Ratio75.527+22%58.90058.9000%66.030-11%79.817-26%62.314-5%
Price To Total Gains Ratio20.810+22%16.22916.2290%42.948-62%37.898-57%67.263-76%
Quick Ratio--0.9860.9860%2.274-57%1.741-43%1.318-25%
Return On Assets--0.0490.0490%0.055-10%0.105-53%0.082-40%
Return On Equity--0.0860.0860%0.081+7%0.148-41%0.121-28%
Total Gains Per Share--76.29876.2980%18.867+304%39.894+91%24.838+207%
Usd Book Value--919513000.000919513000.0000%695200380.000+32%651239162.000+41%477152277.000+93%
Usd Book Value Change Per Share--0.8840.8840%0.177+400%0.432+105%0.271+227%
Usd Book Value Per Share--3.6243.6240%2.740+32%2.567+41%1.881+93%
Usd Dividend Per Share--0.0240.0240%0.048-50%0.043-44%0.025-5%
Usd Eps--0.2570.2570%0.221+16%0.342-25%0.229+12%
Usd Free Cash Flow--63469840.00063469840.0000%37049460.000+71%52558968.000+21%37165009.000+71%
Usd Free Cash Flow Per Share--0.2500.2500%0.146+71%0.207+21%0.146+71%
Usd Free Cash Flow To Equity Per Share--0.2500.2500%0.384-35%0.253-1%0.137+82%
Usd Market Cap4793691413.280+22%3738376050.4683738376050.4680%2446360700.645+53%3864784235.963-3%2982774501.185+25%
Usd Price Per Share18.895+22%14.73514.7350%9.643+53%15.233-3%11.757+25%
Usd Profit--65134650.00065134650.0000%56087080.000+16%86848104.000-25%58015356.000+12%
Usd Revenue--907066790.000907066790.0000%743074080.000+22%708439606.000+28%548447795.000+65%
Usd Total Gains Per Share--0.9080.9080%0.225+304%0.475+91%0.296+207%
 EOD+4 -4MRQTTM+0 -0YOY+21 -145Y+14 -2110Y+25 -10

3.3 Fundamental Score

Let's check the fundamental score of IPCA LABORATORIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1573.597
Price to Book Ratio (EOD)Between0-15.213
Net Profit Margin (MRQ)Greater than00.072
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.986
Current Ratio (MRQ)Greater than12.351
Debt to Asset Ratio (MRQ)Less than10.304
Debt to Equity Ratio (MRQ)Less than10.533
Return on Equity (MRQ)Greater than0.150.086
Return on Assets (MRQ)Greater than0.050.049
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of IPCA LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.771
Ma 20Greater thanMa 501,598.530
Ma 50Greater thanMa 1001,501.160
Ma 100Greater thanMa 2001,368.379
OpenGreater thanClose1,566.700
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About IPCA LABORATORIES LTD.

Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-10-24 12:57:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Ipca earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Ipca to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 7.2% means that ₹0.07 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IPCA LABORATORIES LTD.:

  • The MRQ is 7.2%. The company is making a profit. +1
  • The TTM is 7.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ7.2%TTM7.2%0.0%
TTM7.2%YOY7.5%-0.4%
TTM7.2%5Y12.8%-5.6%
5Y12.8%10Y10.0%+2.8%
4.3.1.2. Return on Assets

Shows how efficient Ipca is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ipca to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.9% Return on Assets means that Ipca generated ₹0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IPCA LABORATORIES LTD.:

  • The MRQ is 4.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.9%TTM4.9%0.0%
TTM4.9%YOY5.5%-0.5%
TTM4.9%5Y10.5%-5.5%
5Y10.5%10Y8.2%+2.3%
4.3.1.3. Return on Equity

Shows how efficient Ipca is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ipca to the Drug Manufacturers - Specialty & Generic industry mean.
  • 8.6% Return on Equity means Ipca generated ₹0.09 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IPCA LABORATORIES LTD.:

  • The MRQ is 8.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.6%TTM8.6%0.0%
TTM8.6%YOY8.1%+0.6%
TTM8.6%5Y14.8%-6.1%
5Y14.8%10Y12.1%+2.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of IPCA LABORATORIES LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Ipca is operating .

  • Measures how much profit Ipca makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ipca to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IPCA LABORATORIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY12.7%-12.7%
TTM-5Y14.2%-14.2%
5Y14.2%10Y11.9%+2.3%
4.3.2.2. Operating Ratio

Measures how efficient Ipca is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.24 means that the operating costs are ₹1.24 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of IPCA LABORATORIES LTD.:

  • The MRQ is 1.235. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.235. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.235TTM1.2350.000
TTM1.235YOY1.331-0.096
TTM1.2355Y1.228+0.007
5Y1.22810Y1.268-0.040
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of IPCA LABORATORIES LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Ipca is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.35 means the company has ₹2.35 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of IPCA LABORATORIES LTD.:

  • The MRQ is 2.351. The company is able to pay all its short-term debts. +1
  • The TTM is 2.351. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.351TTM2.3510.000
TTM2.351YOY2.874-0.522
TTM2.3515Y2.676-0.325
5Y2.67610Y2.276+0.400
4.4.3.2. Quick Ratio

Measures if Ipca is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ipca to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.99 means the company can pay off ₹0.99 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IPCA LABORATORIES LTD.:

  • The MRQ is 0.986. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.986. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.986TTM0.9860.000
TTM0.986YOY2.274-1.288
TTM0.9865Y1.741-0.755
5Y1.74110Y1.318+0.423
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of IPCA LABORATORIES LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Ipca assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ipca to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.30 means that Ipca assets are financed with 30.4% credit (debt) and the remaining percentage (100% - 30.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IPCA LABORATORIES LTD.:

  • The MRQ is 0.304. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.304. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.304TTM0.3040.000
TTM0.304YOY0.323-0.019
TTM0.3045Y0.289+0.015
5Y0.28910Y0.333-0.044
4.5.4.2. Debt to Equity Ratio

Measures if Ipca is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ipca to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 53.3% means that company has ₹0.53 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IPCA LABORATORIES LTD.:

  • The MRQ is 0.533. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.533. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.533TTM0.5330.000
TTM0.533YOY0.477+0.056
TTM0.5335Y0.429+0.104
5Y0.42910Y0.520-0.091
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Ipca generates.

  • Above 15 is considered overpriced but always compare Ipca to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 57.39 means the investor is paying ₹57.39 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IPCA LABORATORIES LTD.:

  • The EOD is 73.597. Based on the earnings, the company is expensive. -2
  • The MRQ is 57.395. Based on the earnings, the company is expensive. -2
  • The TTM is 57.395. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD73.597MRQ57.395+16.202
MRQ57.395TTM57.3950.000
TTM57.395YOY43.617+13.777
TTM57.3955Y46.378+11.016
5Y46.37810Y66.026-19.648
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of IPCA LABORATORIES LTD.:

  • The EOD is 75.527. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 58.900. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 58.900. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD75.527MRQ58.900+16.627
MRQ58.900TTM58.9000.000
TTM58.900YOY66.030-7.130
TTM58.9005Y79.817-20.917
5Y79.81710Y62.314+17.503
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Ipca is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 4.07 means the investor is paying ₹4.07 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of IPCA LABORATORIES LTD.:

  • The EOD is 5.213. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.066. Based on the equity, the company is fair priced.
  • The TTM is 4.066. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.213MRQ4.066+1.148
MRQ4.066TTM4.0660.000
TTM4.066YOY3.519+0.547
TTM4.0665Y6.497-2.432
5Y6.49710Y6.694-0.196
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets111,012,800
Total Liabilities33,742,800
Total Stockholder Equity63,321,900
 As reported
Total Liabilities 33,742,800
Total Stockholder Equity+ 63,321,900
Total Assets = 111,012,800

Assets

Total Assets111,012,800
Total Current Assets55,389,000
Long-term Assets55,623,800
Total Current Assets
Cash And Cash Equivalents 2,089,100
Short-term Investments 6,364,400
Net Receivables 16,865,100
Inventory 24,713,100
Other Current Assets 99,200
Total Current Assets  (as reported)55,389,000
Total Current Assets  (calculated)50,130,900
+/- 5,258,100
Long-term Assets
Property Plant Equipment 46,631,000
Goodwill 905,800
Intangible Assets 1,426,000
Long-term Assets Other 215,300
Long-term Assets  (as reported)55,623,800
Long-term Assets  (calculated)49,178,100
+/- 6,445,700

Liabilities & Shareholders' Equity

Total Current Liabilities23,556,400
Long-term Liabilities10,186,400
Total Stockholder Equity63,321,900
Total Current Liabilities
Short Long Term Debt 8,070,900
Accounts payable 7,760,800
Other Current Liabilities 1,222,300
Total Current Liabilities  (as reported)23,556,400
Total Current Liabilities  (calculated)17,054,000
+/- 6,502,400
Long-term Liabilities
Long term Debt 5,804,100
Capital Lease Obligations Min Short Term Debt508,600
Long-term Liabilities Other 9,900
Long-term Liabilities  (as reported)10,186,400
Long-term Liabilities  (calculated)6,322,600
+/- 3,863,800
Total Stockholder Equity
Retained Earnings 48,993,500
Total Stockholder Equity (as reported)63,321,900
Total Stockholder Equity (calculated)48,993,500
+/- 14,328,400
Other
Capital Stock253,700
Common Stock Shares Outstanding 253,704
Net Debt 11,785,900
Net Invested Capital 77,196,900
Net Working Capital 31,832,600
Property Plant and Equipment Gross 69,165,500



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
32,105,600
38,123,600
38,917,100
39,595,100
41,173,000
45,506,700
52,598,300
60,683,600
76,235,300
86,264,300
111,012,800
111,012,80086,264,30076,235,30060,683,60052,598,30045,506,70041,173,00039,595,10038,917,10038,123,60032,105,600
   > Total Current Assets 
16,014,200
16,139,800
16,219,200
17,418,200
19,454,800
23,777,500
28,557,100
34,369,600
44,571,700
51,892,700
55,389,000
55,389,00051,892,70044,571,70034,369,60028,557,10023,777,50019,454,80017,418,20016,219,20016,139,80016,014,200
       Cash And Cash Equivalents 
760,100
1,247,900
15,600
13,400
13,700
6,000
37,300
1,059,700
721,900
916,800
2,089,100
2,089,100916,800721,9001,059,70037,3006,00013,70013,40015,6001,247,900760,100
       Short-term Investments 
1,500
0
0
1,135,700
693,500
903,800
3,594,000
6,028,400
10,948,600
9,295,400
6,364,400
6,364,4009,295,40010,948,6006,028,4003,594,000903,800693,5001,135,700001,500
       Net Receivables 
6,062,600
5,071,300
4,501,700
6,694,100
8,125,700
8,733,500
8,952,000
8,117,500
9,107,800
9,890,200
16,865,100
16,865,1009,890,2009,107,8008,117,5008,952,0008,733,5008,125,7006,694,1004,501,7005,071,3006,062,600
       Inventory 
8,475,800
9,265,600
8,420,000
8,822,200
8,805,900
10,725,000
13,231,200
15,948,100
18,579,700
17,433,700
24,713,100
24,713,10017,433,70018,579,70015,948,10013,231,20010,725,0008,805,9008,822,2008,420,0009,265,6008,475,800
       Other Current Assets 
617,500
452,400
101,800
279,500
169,200
450,600
255,200
517,700
829,700
2,770,900
99,200
99,2002,770,900829,700517,700255,200450,600169,200279,500101,800452,400617,500
   > Long-term Assets 
0
0
0
22,255,200
21,718,200
21,729,200
24,041,200
26,314,000
31,816,900
34,371,600
55,623,800
55,623,80034,371,60031,816,90026,314,00024,041,20021,729,20021,718,20022,255,200000
       Property Plant Equipment 
14,465,900
19,557,100
20,355,000
19,755,000
18,954,000
17,825,600
19,932,800
21,464,500
25,026,000
26,945,800
46,631,000
46,631,00026,945,80025,026,00021,464,50019,932,80017,825,60018,954,00019,755,00020,355,00019,557,10014,465,900
       Goodwill 
461,800
580,500
472,000
472,000
472,000
472,000
624,400
466,000
388,400
381,400
905,800
905,800381,400388,400466,000624,400472,000472,000472,000472,000580,500461,800
       Long Term Investments 
90,000
161,900
258,200
222,400
0
0
0
0
0
0
0
0000000222,400258,200161,90090,000
       Intangible Assets 
257,200
538,900
602,200
552,100
833,600
1,769,500
1,363,200
1,142,000
1,671,900
1,590,900
1,426,000
1,426,0001,590,9001,671,9001,142,0001,363,2001,769,500833,600552,100602,200538,900257,200
       Long-term Assets Other 
0
0
0
2,400
100
16,500
21,900
8,800
15,100
521,600
215,300
215,300521,60015,1008,80021,90016,5001002,400000
> Total Liabilities 
12,509,000
16,039,300
16,325,200
15,042,500
14,287,300
14,282,800
16,323,500
13,667,100
21,586,900
27,844,100
33,742,800
33,742,80027,844,10021,586,90013,667,10016,323,50014,282,80014,287,30015,042,50016,325,20016,039,30012,509,000
   > Total Current Liabilities 
7,914,500
9,043,600
9,699,500
9,559,300
10,075,700
10,975,000
13,264,200
11,605,400
14,658,800
18,058,200
23,556,400
23,556,40018,058,20014,658,80011,605,40013,264,20010,975,00010,075,7009,559,3009,699,5009,043,6007,914,500
       Short-term Debt 
6,025,600
9,349,900
1,848,500
1,773,000
2,390,400
2,096,900
3,109,500
1,766,100
3,678,100
6,618,200
0
06,618,2003,678,1001,766,1003,109,5002,096,9002,390,4001,773,0001,848,5009,349,9006,025,600
       Short Long Term Debt 
6,025,600
9,349,900
8,671,800
7,157,500
3,935,500
3,241,000
3,788,600
2,158,000
3,960,600
8,057,500
8,070,900
8,070,9008,057,5003,960,6002,158,0003,788,6003,241,0003,935,5007,157,5008,671,8009,349,9006,025,600
       Accounts payable 
3,409,900
3,065,900
4,211,100
3,965,400
4,234,700
5,243,200
6,098,500
6,648,600
5,577,000
5,250,600
7,760,800
7,760,8005,250,6005,577,0006,648,6006,098,5005,243,2004,234,7003,965,4004,211,1003,065,9003,409,900
       Other Current Liabilities 
946,800
1,120,900
1,258,000
1,627,200
1,613,700
2,271,100
2,883,800
1,977,400
4,448,100
4,683,500
1,222,300
1,222,3004,683,5004,448,1001,977,4002,883,8002,271,1001,613,7001,627,2001,258,0001,120,900946,800
   > Long-term Liabilities 
0
0
0
5,483,200
4,211,600
3,152,400
2,923,000
2,190,500
6,041,900
9,052,900
10,186,400
10,186,4009,052,9006,041,9002,190,5002,923,0003,152,4004,211,6005,483,200000
       Long term Debt Total 
0
0
4,842,700
3,517,400
2,340,100
1,408,500
1,159,900
173,800
4,066,800
6,688,600
0
06,688,6004,066,800173,8001,159,9001,408,5002,340,1003,517,4004,842,70000
       Capital Lease Obligations 
0
0
0
0
0
0
188,900
130,500
159,800
237,400
508,600
508,600237,400159,800130,500188,900000000
       Long-term Liabilities Other 
0
0
0
15,600
15,600
15,600
15,600
15,600
16,600
2,800
9,900
9,9002,80016,60015,60015,60015,60015,60015,600000
> Total Stockholder Equity
19,596,600
22,084,300
22,591,900
24,552,600
26,885,700
31,223,900
36,274,800
47,016,500
54,648,400
58,420,200
63,321,900
63,321,90058,420,20054,648,40047,016,50036,274,80031,223,90026,885,70024,552,60022,591,90022,084,30019,596,600
   Common Stock
252,400
252,400
252,400
252,400
252,400
252,700
252,700
253,700
253,700
253,700
0
0253,700253,700253,700252,700252,700252,400252,400252,400252,400252,400
   Retained Earnings 
18,655,600
21,121,000
21,936,100
23,800,900
26,107,000
30,422,700
35,194,300
45,588,000
53,471,100
57,219,100
48,993,500
48,993,50057,219,10053,471,10045,588,00035,194,30030,422,70026,107,00023,800,90021,936,10021,121,00018,655,600
   Capital Surplus 
0
0
439,900
439,900
439,900
488,700
488,700
965,200
965,200
965,200
0
0965,200965,200965,200488,700488,700439,900439,900439,90000
   Treasury Stock00000000000
   Other Stockholders Equity 
248,700
271,000
-36,500
59,400
86,400
59,800
339,100
209,600
229,700
58,166,500
0
058,166,500229,700209,600339,10059,80086,40059,400-36,500271,000248,700



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue76,224,100
Cost of Revenue-27,257,900
Gross Profit48,966,20048,966,200
 
Operating Income (+$)
Gross Profit48,966,200
Operating Expense-66,879,400
Operating Income9,344,700-17,913,200
 
Operating Expense (+$)
Research Development718,300
Selling General Administrative8,260,300
Selling And Marketing Expenses0
Operating Expense66,879,4008,978,600
 
Net Interest Income (+$)
Interest Income629,300
Interest Expense-1,372,900
Other Finance Cost-34,600
Net Interest Income-778,200
 
Pretax Income (+$)
Operating Income9,344,700
Net Interest Income-778,200
Other Non-Operating Income Expenses0
Income Before Tax (EBT)8,426,7009,344,700
EBIT - interestExpense = -1,372,900
5,473,500
6,846,400
Interest Expense1,372,900
Earnings Before Interest and Taxes (EBIT)09,799,600
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax8,426,700
Tax Provision-3,134,600
Net Income From Continuing Ops5,229,2005,292,100
Net Income5,473,500
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0778,200
 

Technical Analysis of Ipca
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ipca. The general trend of Ipca is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ipca's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of IPCA LABORATORIES LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1,709.

The bearish price targets are: 1,528 > 1,493 > 1,430.

Tweet this
IPCA LABORATORIES LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of IPCA LABORATORIES LTD.. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

IPCA LABORATORIES LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of IPCA LABORATORIES LTD.. The current macd is 23.85.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ipca price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ipca. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ipca price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
IPCA LABORATORIES LTD. Daily Moving Average Convergence/Divergence (MACD) ChartIPCA LABORATORIES LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of IPCA LABORATORIES LTD.. The current adx is 24.17.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ipca shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
IPCA LABORATORIES LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of IPCA LABORATORIES LTD.. The current sar is 1,660.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
IPCA LABORATORIES LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of IPCA LABORATORIES LTD.. The current rsi is 54.77. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
IPCA LABORATORIES LTD. Daily Relative Strength Index (RSI) ChartIPCA LABORATORIES LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of IPCA LABORATORIES LTD.. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ipca price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
IPCA LABORATORIES LTD. Daily Stochastic Oscillator ChartIPCA LABORATORIES LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of IPCA LABORATORIES LTD.. The current cci is -22.65377576.

IPCA LABORATORIES LTD. Daily Commodity Channel Index (CCI) ChartIPCA LABORATORIES LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of IPCA LABORATORIES LTD.. The current cmo is 2.89685366.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
IPCA LABORATORIES LTD. Daily Chande Momentum Oscillator (CMO) ChartIPCA LABORATORIES LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of IPCA LABORATORIES LTD.. The current willr is -56.05006954.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ipca is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
IPCA LABORATORIES LTD. Daily Williams %R ChartIPCA LABORATORIES LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of IPCA LABORATORIES LTD..

IPCA LABORATORIES LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of IPCA LABORATORIES LTD.. The current atr is 46.00.

IPCA LABORATORIES LTD. Daily Average True Range (ATR) ChartIPCA LABORATORIES LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of IPCA LABORATORIES LTD.. The current obv is 396,583.

IPCA LABORATORIES LTD. Daily On-Balance Volume (OBV) ChartIPCA LABORATORIES LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of IPCA LABORATORIES LTD.. The current mfi is 47.37.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
IPCA LABORATORIES LTD. Daily Money Flow Index (MFI) ChartIPCA LABORATORIES LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for IPCA LABORATORIES LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

IPCA LABORATORIES LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of IPCA LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.771
Ma 20Greater thanMa 501,598.530
Ma 50Greater thanMa 1001,501.160
Ma 100Greater thanMa 2001,368.379
OpenGreater thanClose1,566.700
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Ipca with someone you think should read this too:
  • Are you bullish or bearish on Ipca? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ipca? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about IPCA LABORATORIES LTD.

I send you an email if I find something interesting about IPCA LABORATORIES LTD..


Comments

How you think about this?

Leave a comment

Stay informed about IPCA LABORATORIES LTD..

Receive notifications about IPCA LABORATORIES LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.